Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangqiu Fu

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|September 27, 2023
ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung CancerFangqiu Fu, Yang Zhang, Haiquan Chen
Cell Research|July 21, 2023
Treating lung cancer: defining surgical curative time windowFangqiu Fu, Zongwei Chen, Haiquan Chen
Annals of Surgical Oncology|August 24, 2023
ASO Author Reflections: Long-Term Prognostic Factors for Stage IB Lung Cancer Patients: Pulmonary Groud-Glass Opacity or Visceral Pleural Invasion?Zijiang Yang, Fangqiu Fu, Yang Zhang
The Annals of Thoracic Surgery|June 30, 2026
Intraoperative Frozen Section for IASLC Grading: A Step Toward Individualized SurgeryFangqiu Fu, Yuan Li, Haiquan Chen
The Annals of Thoracic Surgery|June 12, 2020
Management of Ground-Glass Opacities in the Lung Cancer SpectrumYang Zhang, Fangqiu Fu, Haiquan Chen
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2024
The evolution of the treatment of non-small cell lung cancer: A shift in surgical paradigm to a more individualized approachTong Li, Yang Zhang, Fangqiu Fu, et al.
Translational Lung Cancer Research|February 11, 2021
Lung cancer screening strategy for non-high-risk individuals: a narrative reviewFangqiu Fu, Yaodong Zhou, Yang Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
Emerging High-Risk Population of Lung Cancer: To Reveal the UnrevealedFangqiu Fu, Yang Zhang, Na He, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort studyZhanming Ma, Fangqiu Fu, Yang Zhang, et al.
Journal of Thoracic Disease|August 15, 2024
Protocol for a single-arm, multicenter, prospective, confirmatory phase III trial of wedge resection for invasive ground glass opacity-featured lung cancer with a size ≤2 cm and a consolidation tumor ratio between 0.25 and 0.5 (ECTOP-1020 study)Tong Li, Fangqiu Fu, Yang Zhang, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|September 27, 2023
ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung CancerFangqiu Fu, Yang Zhang, Haiquan Chen
Cell Research|July 21, 2023
Treating lung cancer: defining surgical curative time windowFangqiu Fu, Zongwei Chen, Haiquan Chen
Annals of Surgical Oncology|August 24, 2023
ASO Author Reflections: Long-Term Prognostic Factors for Stage IB Lung Cancer Patients: Pulmonary Groud-Glass Opacity or Visceral Pleural Invasion?Zijiang Yang, Fangqiu Fu, Yang Zhang
The Annals of Thoracic Surgery|June 30, 2026
Intraoperative Frozen Section for IASLC Grading: A Step Toward Individualized SurgeryFangqiu Fu, Yuan Li, Haiquan Chen
The Annals of Thoracic Surgery|June 12, 2020
Management of Ground-Glass Opacities in the Lung Cancer SpectrumYang Zhang, Fangqiu Fu, Haiquan Chen
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2024
The evolution of the treatment of non-small cell lung cancer: A shift in surgical paradigm to a more individualized approachTong Li, Yang Zhang, Fangqiu Fu, et al.
Translational Lung Cancer Research|February 11, 2021
Lung cancer screening strategy for non-high-risk individuals: a narrative reviewFangqiu Fu, Yaodong Zhou, Yang Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
Emerging High-Risk Population of Lung Cancer: To Reveal the UnrevealedFangqiu Fu, Yang Zhang, Na He, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort studyZhanming Ma, Fangqiu Fu, Yang Zhang, et al.
Journal of Thoracic Disease|August 15, 2024
Protocol for a single-arm, multicenter, prospective, confirmatory phase III trial of wedge resection for invasive ground glass opacity-featured lung cancer with a size ≤2 cm and a consolidation tumor ratio between 0.25 and 0.5 (ECTOP-1020 study)Tong Li, Fangqiu Fu, Yang Zhang, et al.
Pageof 10